100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Grant Awards
Project Grant R43HD101175
Award Date
4/6/20
Completion Date
9/30/22
Dollars Obligated
$225K
Overview
Activity
4
Transactions
4
Subawards
Similar Awards
Federal Agency
National Institute of Child Health and Human Development
Awardee
Pyrames Inc. (XHDCGYE3NM15)
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Cupertino, CA 95014, USA
Update #1
Update #2
CONTINUOUS NON-INVASIVE BLOOD PRESSURE MONITOR FOR NEONATES
Posted 3/31/20
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
CONTINUOUS NON-INVASIVE BLOOD PRESSURE MONITOR FOR NEONATES - SUMMARY/ABSTRACT EACH YEAR, ABOUT 5-18% OF BABIES ARE BORN PRETERM, ACCOUNTING FOR OVER 0.5M BIRTHS IN THE US AND 15M GLOBALLY. MANY OF THESE BABIES ARE ADMITTED TO NEONATAL INTENSIVE CARE UNITS (NICUS) WHERE THE MEDICAL STAFF GENERALLY HAVE THE OPTION OF USING EITHER INVASIVE ARTERIAL LINES (IALS) OR INFLATABLE-CUFF NON-INVASIVE BLOOD PRESSURE (NIBP) MONITORING. THE FORMER INTRODUCES THE RISK OF INFECTION, TISSUE AND NERVE DAMAGE, AND THE LATTER IS LESS ACCURATE, ESPECIALLY FOR HYPOTENSIVE INFANTS, AND MAY ADD THE RISK OF ISCHEMIC AND NERVE DAMAGE UPON REPEATED MEASUREMENT. THERE IS A CLEAR NEED FOR A SAFER, CONTINUOUS, AND COST EFFECTIVE FORM OF NIBP MEASUREMENT TO MEET THE CHALLENGE OF MANAGING UNHEALTHY BLOOD PRESSURES FOR NEONATES. PYRAMES INC. HAS DEVELOPED A NOVEL CAPACITIVE SENSOR TECHNOLOGY THAT IS PAPER THIN AND FLEXIBLE AND CAN ACCURATELY DETECT BLOOD PRESSURE (BP). THIS SENSOR TECHNOLOGY IS PART OF A UNIQUE CONTINUOUS BP MONITORING PLATFORM THAT PROVIDES ACCURATE, LIGHTWEIGHT AND COMFORTABLE BP MONITORING IN A WIRELESS, WRIST-WORN PACKAGE THAT IS EASY TO USE. THE SYSTEM USES LIGHTWEIGHT NEURAL NETWORKS TO ANALYZE PULSE WAVEFORM DATA TO PROVIDE CONTINUOUS DETERMINATION OF SYSTOLIC, DIASTOLIC, AND MEAN BP, HEART RATE, AND THEIR VARIABILITIES. THE SENSOR IS EASY TO APPLY NON-INVASIVELY AND RECORDS PULSATILE DATA SIMILAR TO AN ARTERIAL LINE, WHILE AVOIDING THE DIFFICULTIES OF PLACING AND MAINTAINING AN ARTERIAL LINE. THIS DEVICE CAN PROVIDE GOLD STANDARD BP MONITORING WITHOUT PERTURBING THE PATIENTS FOR MORE ACCURATE AND RELEVANT MEASUREMENTS. THE OBJECTIVE OF THIS PROJECT IS TO EXTEND THE PLATFORM FOR USE WITH TERM AND PRE-TERM NEONATES. THIS GOAL WILL BE ACCOMPLISHED THROUGH REDESIGN OF THE SENSOR HARDWARE AND OPTIMIZATION OF THE DATA ANALYTICS SOFTWARE. WE WILL VALIDATE THESE MODIFICATIONS WITH CLINICAL DATA FROM THE NICU AT STANFORD UNIVERSITY MEDICAL CENTER. IN PHASE I, WE WILL MINIATURIZE THE ELECTRONICS AND MODIFY THE SENSOR ARRAY OF A WRIST-WORN PULSE WAVE MONITOR TO BE SIZED MORE APPROPRIATELY FOR NEONATES. WE WILL VALIDATE THE NEW DEVICE DESIGN BY COLLECTING NICU CLINICAL DATA FROM PATIENTS WHO HAVE IALS IN PLACE IN AN IRB-APPROVED STUDY. FROM IAL AND SENSOR DATA TAKEN SIMULTANEOUSLY, WE WILL DETERMINE GROUND TRUTH VALUES ON A PULSE-BY-PULSE BASIS AND USE THESE DATA IN CONJUNCTION WITH ADDITIONAL IAL DATA FROM HISTORICAL DATABASES TO IMPROVE OUR SENSOR QUALITY AND PREDICTIVE BP MODELS. OUR SUCCESS METRIC WILL BE TO EQUAL OR EXCEED THE QUALITY AND ACCURACY OF OUR DATA FOR ADULTS. PHASE II WILL BE A FOLLOW-UP IRB-APPROVED PIVOTAL STUDY USING THE DEVICE FROM PHASE 1 TO POSITION OUR DEVICE FOR FDA SUBMISSION AND CLEARANCE AND SCALE UP TO PILOT PRODUCTION OF THIS DEVICE.
0$
10/13/23
Not listed
CONTINUOUS NON-INVASIVE BLOOD PRESSURE MONITOR FOR NEONATES - SUMMARY/ABSTRACT EACH YEAR, ABOUT 5-18% OF BABIES ARE BORN PRETERM, ACCOUNTING FOR OVER 0.5M BIRTHS IN THE US AND 15M GLOBALLY. MANY OF THESE BABIES ARE ADMITTED TO NEONATAL INTENSIVE CARE UNITS (NICUS) WHERE THE MEDICAL STAFF GENERALLY HAVE THE OPTION OF USING EITHER INVASIVE ARTERIAL LINES (IALS) OR INFLATABLE-CUFF NON-INVASIVE BLOOD PRESSURE (NIBP) MONITORING. THE FORMER INTRODUCES THE RISK OF INFECTION, TISSUE AND NERVE DAMAGE, AND THE LATTER IS LESS ACCURATE, ESPECIALLY FOR HYPOTENSIVE INFANTS, AND MAY ADD THE RISK OF ISCHEMIC AND NERVE DAMAGE UPON REPEATED MEASUREMENT. THERE IS A CLEAR NEED FOR A SAFER, CONTINUOUS, AND COST EFFECTIVE FORM OF NIBP MEASUREMENT TO MEET THE CHALLENGE OF MANAGING UNHEALTHY BLOOD PRESSURES FOR NEONATES. PYRAMES INC. HAS DEVELOPED A NOVEL CAPACITIVE SENSOR TECHNOLOGY THAT IS PAPER THIN AND FLEXIBLE AND CAN ACCURATELY DETECT BLOOD PRESSURE (BP). THIS SENSOR TECHNOLOGY IS PART OF A UNIQUE CONTINUOUS BP MONITORING PLATFORM THAT PROVIDES ACCURATE, LIGHTWEIGHT AND COMFORTABLE BP MONITORING IN A WIRELESS, WRIST-WORN PACKAGE THAT IS EASY TO USE. THE SYSTEM USES LIGHTWEIGHT NEURAL NETWORKS TO ANALYZE PULSE WAVEFORM DATA TO PROVIDE CONTINUOUS DETERMINATION OF SYSTOLIC, DIASTOLIC, AND MEAN BP, HEART RATE, AND THEIR VARIABILITIES. THE SENSOR IS EASY TO APPLY NON-INVASIVELY AND RECORDS PULSATILE DATA SIMILAR TO AN ARTERIAL LINE, WHILE AVOIDING THE DIFFICULTIES OF PLACING AND MAINTAINING AN ARTERIAL LINE. THIS DEVICE CAN PROVIDE GOLD STANDARD BP MONITORING WITHOUT PERTURBING THE PATIENTS FOR MORE ACCURATE AND RELEVANT MEASUREMENTS. THE OBJECTIVE OF THIS PROJECT IS TO EXTEND THE PLATFORM FOR USE WITH TERM AND PRE-TERM NEONATES. THIS GOAL WILL BE ACCOMPLISHED THROUGH REDESIGN OF THE SENSOR HARDWARE AND OPTIMIZATION OF THE DATA ANALYTICS SOFTWARE. WE WILL VALIDATE THESE MODIFICATIONS WITH CLINICAL DATA FROM THE NICU AT STANFORD UNIVERSITY MEDICAL CENTER. IN PHASE I, WE WILL MINIATURIZE THE ELECTRONICS AND MODIFY THE SENSOR ARRAY OF A WRIST-WORN PULSE WAVE MONITOR TO BE SIZED MORE APPROPRIATELY FOR NEONATES. WE WILL VALIDATE THE NEW DEVICE DESIGN BY COLLECTING NICU CLINICAL DATA FROM PATIENTS WHO HAVE IALS IN PLACE IN AN IRB-APPROVED STUDY. FROM IAL AND SENSOR DATA TAKEN SIMULTANEOUSLY, WE WILL DETERMINE GROUND TRUTH VALUES ON A PULSE-BY-PULSE BASIS AND USE THESE DATA IN CONJUNCTION WITH ADDITIONAL IAL DATA FROM HISTORICAL DATABASES TO IMPROVE OUR SENSOR QUALITY AND PREDICTIVE BP MODELS. OUR SUCCESS METRIC WILL BE TO EQUAL OR EXCEED THE QUALITY AND ACCURACY OF OUR DATA FOR ADULTS. PHASE II WILL BE A FOLLOW-UP IRB-APPROVED PIVOTAL STUDY USING THE DEVICE FROM PHASE 1 TO POSITION OUR DEVICE FOR FDA SUBMISSION AND CLEARANCE AND SCALE UP TO PILOT PRODUCTION OF THIS DEVICE.
$0
3/9/22
Not listed
CONTINUOUS NON-INVASIVE BLOOD PRESSURE MONITOR FOR NEONATES - SUMMARY/ABSTRACT EACH YEAR, ABOUT 5-18% OF BABIES ARE BORN PRETERM, ACCOUNTING FOR OVER 0.5M BIRTHS IN THE US AND 15M GLOBALLY. MANY OF THESE BABIES ARE ADMITTED TO NEONATAL INTENSIVE CARE UNITS (NICUS) WHERE THE MEDICAL STAFF GENERALLY HAVE THE OPTION OF USING EITHER INVASIVE ARTERIAL LINES (IALS) OR INFLATABLE-CUFF NON-INVASIVE BLOOD PRESSURE (NIBP) MONITORING. THE FORMER INTRODUCES THE RISK OF INFECTION, TISSUE AND NERVE DAMAGE, AND THE LATTER IS LESS ACCURATE, ESPECIALLY FOR HYPOTENSIVE INFANTS, AND MAY ADD THE RISK OF ISCHEMIC AND NERVE DAMAGE UPON REPEATED MEASUREMENT. THERE IS A CLEAR NEED FOR A SAFER, CONTINUOUS, AND COST EFFECTIVE FORM OF NIBP MEASUREMENT TO MEET THE CHALLENGE OF MANAGING UNHEALTHY BLOOD PRESSURES FOR NEONATES. PYRAMES INC. HAS DEVELOPED A NOVEL CAPACITIVE SENSOR TECHNOLOGY THAT IS PAPER THIN AND FLEXIBLE AND CAN ACCURATELY DETECT BLOOD PRESSURE (BP). THIS SENSOR TECHNOLOGY IS PART OF A UNIQUE CONTINUOUS BP MONITORING PLATFORM THAT PROVIDES ACCURATE, LIGHTWEIGHT AND COMFORTABLE BP MONITORING IN A WIRELESS, WRIST-WORN PACKAGE THAT IS EASY TO USE. THE SYSTEM USES LIGHTWEIGHT NEURAL NETWORKS TO ANALYZE PULSE WAVEFORM DATA TO PROVIDE CONTINUOUS DETERMINATION OF SYSTOLIC, DIASTOLIC, AND MEAN BP, HEART RATE, AND THEIR VARIABILITIES. THE SENSOR IS EASY TO APPLY NON-INVASIVELY AND RECORDS PULSATILE DATA SIMILAR TO AN ARTERIAL LINE, WHILE AVOIDING THE DIFFICULTIES OF PLACING AND MAINTAINING AN ARTERIAL LINE. THIS DEVICE CAN PROVIDE GOLD STANDARD BP MONITORING WITHOUT PERTURBING THE PATIENTS FOR MORE ACCURATE AND RELEVANT MEASUREMENTS. THE OBJECTIVE OF THIS PROJECT IS TO EXTEND THE PLATFORM FOR USE WITH TERM AND PRE-TERM NEONATES. THIS GOAL WILL BE ACCOMPLISHED THROUGH REDESIGN OF THE SENSOR HARDWARE AND OPTIMIZATION OF THE DATA ANALYTICS SOFTWARE. WE WILL VALIDATE THESE MODIFICATIONS WITH CLINICAL DATA FROM THE NICU AT STANFORD UNIVERSITY MEDICAL CENTER. IN PHASE I, WE WILL MINIATURIZE THE ELECTRONICS AND MODIFY THE SENSOR ARRAY OF A WRIST-WORN PULSE WAVE MONITOR TO BE SIZED MORE APPROPRIATELY FOR NEONATES. WE WILL VALIDATE THE NEW DEVICE DESIGN BY COLLECTING NICU CLINICAL DATA FROM PATIENTS WHO HAVE IALS IN PLACE IN AN IRB-APPROVED STUDY. FROM IAL AND SENSOR DATA TAKEN SIMULTANEOUSLY, WE WILL DETERMINE GROUND TRUTH VALUES ON A PULSE-BY-PULSE BASIS AND USE THESE DATA IN CONJUNCTION WITH ADDITIONAL IAL DATA FROM HISTORICAL DATABASES TO IMPROVE OUR SENSOR QUALITY AND PREDICTIVE BP MODELS. OUR SUCCESS METRIC WILL BE TO EQUAL OR EXCEED THE QUALITY AND ACCURACY OF OUR DATA FOR ADULTS. PHASE II WILL BE A FOLLOW-UP IRB-APPROVED PIVOTAL STUDY USING THE DEVICE FROM PHASE 1 TO POSITION OUR DEVICE FOR FDA SUBMISSION AND CLEARANCE AND SCALE UP TO PILOT PRODUCTION OF THIS DEVICE.
$0
3/9/22
Not listed
CONTINUOUS NON-INVASIVE BLOOD PRESSURE MONITOR FOR NEONATES
$224.6k
3/31/20